Support for the Microgenderome: Associations in a Human Clinical Population.
Wallis, Amy, Butt, Henry, Ball, Michelle et al. · Scientific reports · 2016 · DOI
Quick Summary
This study looked at gut bacteria in 274 ME/CFS patients and found that certain bacteria may affect symptoms differently in men and women, even when they have similar amounts of these bacteria. Specific bacteria called Firmicutes (including types like Clostridium and Lactobacillus) appeared connected to neurological, immune, and mood symptoms, but the way they affected symptoms depended on the patient's sex. This suggests that sex differences matter when understanding how gut bacteria influence ME/CFS.
Why It Matters
This research highlights that sex differences in microbiota-host interactions may be critical for understanding ME/CFS symptom variation and developing targeted treatments. Recognizing that the same bacteria may have different effects in men versus women could lead to more personalized therapeutic approaches, including microbiota-targeted interventions.
Observed Findings
Significant sex-specific interactions between Firmicutes taxa and ME/CFS symptom severity
Associations between Clostridium, Streptococcus, Lactobacillus, and Enterococcus and neurological, immune, and mood symptoms varied by sex
Sex-specific patterns persisted despite comparable microbial compositional abundance between male and female participants
Some Firmicutes appeared protective against symptoms in one sex while correlating with symptoms in the other
Inferred Conclusions
Sex differences in microbiota-host interactions are relevant to ME/CFS symptom expression and should not be overlooked in microbiota research
Commensal gut bacteria play both beneficial and harmful roles in ME/CFS, with effects modulated by patient sex
The 'microgenderome' paradigm is supported in human ME/CFS populations and warrants further investigation in both basic and clinical research
Remaining Questions
Do these sex-specific microbial associations have a causal role in symptom generation, or are they markers of underlying pathophysiology?
Can microbiota-targeted interventions based on sex-specific profiles improve ME/CFS symptoms?
What biological mechanisms explain why the same bacterial taxa have opposite effects in men versus women?
What This Study Does Not Prove
This study cannot establish causation—it shows associations only, not whether specific bacteria cause symptoms or symptoms alter bacterial composition. The cross-sectional design means we cannot determine direction of effect, and findings have not yet been replicated in independent ME/CFS populations. Sex-specific effects observed here require mechanistic validation in experimental models.